CANTALOUPE INC (CTLP)
US1381031061 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to CTLP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.51. This target is 14.69% above the current price.
CTLP was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CTLP.
In the previous month the buy percentage consensus was at a similar level.
CTLP was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-11 | Benchmark | Reiterate | Buy -> Buy |
| 2024-09-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-12 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-05-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-15 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-06 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2024-03-25 | Benchmark | Reiterate | Buy -> Buy |
| 2024-02-23 | Benchmark | Initiate | Buy |
| 2024-02-14 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2024-01-03 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-10-03 | Berenberg | Initiate | Buy |
| 2023-09-07 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-05-25 | Barrington Research | Reiterate | Outperform |
| 2023-05-12 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-05-02 | Barrington Research | Reiterate | Outperform |
| 2023-02-08 | Barrington Research | Reiterate | Outperform |